Project
Illumina Body Map 2
Navigation
Downloads
Results for PPARA
Z-value: 1.91
Motif logo
Transcription factors associated with PPARA
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PPARA
|
ENSG00000186951.12 | peroxisome proliferator activated receptor alpha |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PPARA | hg19_v2_chr22_+_46546494_46546525 | 0.44 | 1.1e-02 | Click! |
Activity profile of PPARA motif
Sorted Z-values of PPARA motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_-_42744130 | 10.97 |
ENST00000417472.1
ENST00000442469.1 |
HHATL
|
hedgehog acyltransferase-like |
| chrX_-_21776281 | 9.21 |
ENST00000379494.3
|
SMPX
|
small muscle protein, X-linked |
| chr5_+_149569520 | 8.77 |
ENST00000230671.2
ENST00000524041.1 |
SLC6A7
|
solute carrier family 6 (neurotransmitter transporter), member 7 |
| chr1_+_236849754 | 8.26 |
ENST00000542672.1
ENST00000366578.4 |
ACTN2
|
actinin, alpha 2 |
| chr3_-_42744312 | 8.17 |
ENST00000416756.1
ENST00000441594.1 |
HHATL
|
hedgehog acyltransferase-like |
| chr16_+_6069586 | 8.05 |
ENST00000547372.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr16_-_4292071 | 7.50 |
ENST00000399609.3
|
SRL
|
sarcalumenin |
| chr3_-_42744270 | 7.45 |
ENST00000457462.1
|
HHATL
|
hedgehog acyltransferase-like |
| chr1_+_160097462 | 6.97 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr3_-_42743006 | 6.88 |
ENST00000310417.5
|
HHATL
|
hedgehog acyltransferase-like |
| chr16_+_6069664 | 6.73 |
ENST00000422070.4
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr22_+_31518938 | 6.49 |
ENST00000412985.1
ENST00000331075.5 ENST00000412277.2 ENST00000420017.1 ENST00000400294.2 ENST00000405300.1 ENST00000404390.3 |
INPP5J
|
inositol polyphosphate-5-phosphatase J |
| chr20_-_62130474 | 6.37 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr14_-_21492251 | 6.31 |
ENST00000554398.1
|
NDRG2
|
NDRG family member 2 |
| chr1_+_169075554 | 5.54 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr1_+_153600869 | 5.30 |
ENST00000292169.1
ENST00000368696.3 ENST00000436839.1 |
S100A1
|
S100 calcium binding protein A1 |
| chr1_-_229569834 | 5.21 |
ENST00000366684.3
ENST00000366683.2 |
ACTA1
|
actin, alpha 1, skeletal muscle |
| chr16_+_6069072 | 5.16 |
ENST00000547605.1
ENST00000550418.1 ENST00000553186.1 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr8_-_107782463 | 5.07 |
ENST00000311955.3
|
ABRA
|
actin-binding Rho activating protein |
| chr7_+_123241908 | 5.02 |
ENST00000434204.1
ENST00000437535.1 ENST00000451215.1 |
ASB15
|
ankyrin repeat and SOCS box containing 15 |
| chr4_-_65275100 | 5.00 |
ENST00000509536.1
|
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
| chr14_-_21492113 | 4.87 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
| chr19_-_55669093 | 4.75 |
ENST00000344887.5
|
TNNI3
|
troponin I type 3 (cardiac) |
| chr4_-_65275162 | 4.74 |
ENST00000381210.3
ENST00000507440.1 |
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
| chr6_-_33714667 | 4.73 |
ENST00000293756.4
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
| chr20_-_42816206 | 4.62 |
ENST00000372980.3
|
JPH2
|
junctophilin 2 |
| chr5_+_80529104 | 4.54 |
ENST00000254035.4
ENST00000511719.1 ENST00000437669.1 ENST00000424301.2 ENST00000505060.1 |
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric) |
| chr9_+_12693336 | 4.51 |
ENST00000381137.2
ENST00000388918.5 |
TYRP1
|
tyrosinase-related protein 1 |
| chrX_-_21676442 | 4.41 |
ENST00000379499.2
|
KLHL34
|
kelch-like family member 34 |
| chr6_-_33714752 | 4.39 |
ENST00000451316.1
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
| chr11_-_119249805 | 4.33 |
ENST00000527843.1
|
USP2
|
ubiquitin specific peptidase 2 |
| chr1_+_169077133 | 4.22 |
ENST00000494797.1
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr16_+_7560114 | 4.14 |
ENST00000570626.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr2_-_179659669 | 3.93 |
ENST00000436599.1
|
TTN
|
titin |
| chr3_-_47932759 | 3.91 |
ENST00000441748.2
ENST00000335271.5 |
MAP4
|
microtubule-associated protein 4 |
| chr1_-_217250231 | 3.88 |
ENST00000493748.1
ENST00000463665.1 |
ESRRG
|
estrogen-related receptor gamma |
| chr9_+_95997205 | 3.82 |
ENST00000411624.1
|
WNK2
|
WNK lysine deficient protein kinase 2 |
| chr6_+_53948221 | 3.81 |
ENST00000460844.2
|
MLIP
|
muscular LMNA-interacting protein |
| chr1_-_205904950 | 3.79 |
ENST00000340781.4
|
SLC26A9
|
solute carrier family 26 (anion exchanger), member 9 |
| chr3_-_38691119 | 3.66 |
ENST00000333535.4
ENST00000413689.1 ENST00000443581.1 ENST00000425664.1 ENST00000451551.2 |
SCN5A
|
sodium channel, voltage-gated, type V, alpha subunit |
| chr1_+_169077172 | 3.65 |
ENST00000499679.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr9_-_35685452 | 3.60 |
ENST00000607559.1
|
TPM2
|
tropomyosin 2 (beta) |
| chr19_-_42498231 | 3.57 |
ENST00000602133.1
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
| chr1_-_917466 | 3.56 |
ENST00000341290.2
|
C1orf170
|
chromosome 1 open reading frame 170 |
| chr6_+_53948328 | 3.55 |
ENST00000370876.2
|
MLIP
|
muscular LMNA-interacting protein |
| chr18_-_44336998 | 3.54 |
ENST00000315087.7
|
ST8SIA5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
| chr3_+_159557637 | 3.46 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
| chr19_-_49658641 | 3.46 |
ENST00000252825.4
|
HRC
|
histidine rich calcium binding protein |
| chr7_-_44365020 | 3.38 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr15_-_42783303 | 3.37 |
ENST00000565380.1
ENST00000564754.1 |
ZNF106
|
zinc finger protein 106 |
| chr15_+_36887069 | 3.35 |
ENST00000566807.1
ENST00000567389.1 ENST00000562877.1 |
C15orf41
|
chromosome 15 open reading frame 41 |
| chr9_-_140115775 | 3.34 |
ENST00000391553.1
ENST00000392827.1 |
RNF208
|
ring finger protein 208 |
| chr2_+_170366203 | 3.34 |
ENST00000284669.1
|
KLHL41
|
kelch-like family member 41 |
| chr22_+_31523734 | 3.32 |
ENST00000402238.1
ENST00000404453.1 ENST00000401755.1 |
INPP5J
|
inositol polyphosphate-5-phosphatase J |
| chr14_-_65289812 | 3.31 |
ENST00000389720.3
ENST00000389721.5 ENST00000389722.3 |
SPTB
|
spectrin, beta, erythrocytic |
| chr11_-_19223523 | 3.29 |
ENST00000265968.3
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
| chr14_+_32964258 | 3.23 |
ENST00000556638.1
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr12_+_119616447 | 3.17 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
| chr18_-_56296182 | 2.97 |
ENST00000361673.3
|
ALPK2
|
alpha-kinase 2 |
| chr18_-_44336754 | 2.96 |
ENST00000538168.1
ENST00000536490.1 |
ST8SIA5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
| chrX_-_31284974 | 2.87 |
ENST00000378702.4
|
DMD
|
dystrophin |
| chrX_-_31285042 | 2.86 |
ENST00000378680.2
ENST00000378723.3 |
DMD
|
dystrophin |
| chr4_-_109684120 | 2.84 |
ENST00000512646.1
ENST00000411864.2 ENST00000296486.3 ENST00000510706.1 |
ETNPPL
|
ethanolamine-phosphate phospho-lyase |
| chr10_-_97175444 | 2.79 |
ENST00000486141.2
|
SORBS1
|
sorbin and SH3 domain containing 1 |
| chr19_-_42498369 | 2.77 |
ENST00000302102.5
ENST00000545399.1 |
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
| chr17_-_27503770 | 2.69 |
ENST00000533112.1
|
MYO18A
|
myosin XVIIIA |
| chr17_-_79792909 | 2.69 |
ENST00000330261.4
ENST00000570394.1 |
PPP1R27
|
protein phosphatase 1, regulatory subunit 27 |
| chr16_-_31439735 | 2.68 |
ENST00000287490.4
|
COX6A2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
| chr12_-_56105880 | 2.67 |
ENST00000557257.1
|
ITGA7
|
integrin, alpha 7 |
| chr11_-_111783595 | 2.65 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr12_-_114843889 | 2.63 |
ENST00000405440.2
|
TBX5
|
T-box 5 |
| chr7_-_10979750 | 2.61 |
ENST00000339600.5
|
NDUFA4
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa |
| chr5_+_145317356 | 2.59 |
ENST00000511217.1
|
SH3RF2
|
SH3 domain containing ring finger 2 |
| chr3_+_184055240 | 2.59 |
ENST00000383847.2
|
FAM131A
|
family with sequence similarity 131, member A |
| chr19_+_17579556 | 2.58 |
ENST00000442725.1
|
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1 |
| chr1_-_40157345 | 2.57 |
ENST00000372844.3
|
HPCAL4
|
hippocalcin like 4 |
| chr19_+_16771936 | 2.57 |
ENST00000187762.2
ENST00000599479.1 |
TMEM38A
|
transmembrane protein 38A |
| chr5_+_145316120 | 2.52 |
ENST00000359120.4
|
SH3RF2
|
SH3 domain containing ring finger 2 |
| chrX_-_31285018 | 2.52 |
ENST00000361471.4
|
DMD
|
dystrophin |
| chr2_+_220299547 | 2.46 |
ENST00000312358.7
|
SPEG
|
SPEG complex locus |
| chr6_+_133561725 | 2.45 |
ENST00000452339.2
|
EYA4
|
eyes absent homolog 4 (Drosophila) |
| chr16_-_3422283 | 2.44 |
ENST00000399974.3
|
MTRNR2L4
|
MT-RNR2-like 4 |
| chr2_-_207024134 | 2.44 |
ENST00000457011.1
ENST00000440274.1 ENST00000432169.1 |
NDUFS1
|
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) |
| chrX_+_135230712 | 2.38 |
ENST00000535737.1
|
FHL1
|
four and a half LIM domains 1 |
| chr4_-_111563076 | 2.37 |
ENST00000354925.2
ENST00000511990.1 |
PITX2
|
paired-like homeodomain 2 |
| chr5_-_11904100 | 2.36 |
ENST00000359640.2
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr7_+_94536514 | 2.35 |
ENST00000413325.1
|
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
| chr20_+_19870167 | 2.33 |
ENST00000440354.2
|
RIN2
|
Ras and Rab interactor 2 |
| chrX_+_70521584 | 2.33 |
ENST00000373829.3
ENST00000538820.1 |
ITGB1BP2
|
integrin beta 1 binding protein (melusin) 2 |
| chr19_+_35629702 | 2.31 |
ENST00000351325.4
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr6_-_3912207 | 2.30 |
ENST00000566733.1
|
RP1-140K8.5
|
RP1-140K8.5 |
| chr1_+_202317855 | 2.23 |
ENST00000356764.2
|
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
| chr12_-_58026920 | 2.20 |
ENST00000550764.1
ENST00000551220.1 |
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
| chr3_-_46000146 | 2.19 |
ENST00000438446.1
|
FYCO1
|
FYVE and coiled-coil domain containing 1 |
| chr1_-_11907829 | 2.17 |
ENST00000376480.3
|
NPPA
|
natriuretic peptide A |
| chr1_-_217311090 | 2.15 |
ENST00000493603.1
ENST00000366940.2 |
ESRRG
|
estrogen-related receptor gamma |
| chr12_+_109577202 | 2.14 |
ENST00000377848.3
ENST00000377854.5 |
ACACB
|
acetyl-CoA carboxylase beta |
| chr11_+_111896090 | 2.12 |
ENST00000393051.1
|
DLAT
|
dihydrolipoamide S-acetyltransferase |
| chr20_-_42815733 | 2.12 |
ENST00000342272.3
|
JPH2
|
junctophilin 2 |
| chr12_+_120031264 | 2.12 |
ENST00000426426.1
|
TMEM233
|
transmembrane protein 233 |
| chr5_-_11904152 | 2.11 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr4_+_41614720 | 2.11 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
| chr16_+_58535372 | 2.09 |
ENST00000566656.1
ENST00000566618.1 |
NDRG4
|
NDRG family member 4 |
| chr12_-_16759711 | 2.09 |
ENST00000447609.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr15_+_63050785 | 2.09 |
ENST00000472902.1
|
TLN2
|
talin 2 |
| chr18_-_43678241 | 2.08 |
ENST00000593152.2
ENST00000589252.1 ENST00000590665.1 ENST00000398752.6 |
ATP5A1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
| chr6_+_34433844 | 2.07 |
ENST00000244458.2
ENST00000374043.2 |
PACSIN1
|
protein kinase C and casein kinase substrate in neurons 1 |
| chr14_+_76776957 | 2.07 |
ENST00000512784.1
|
ESRRB
|
estrogen-related receptor beta |
| chr1_-_238108575 | 2.06 |
ENST00000604646.1
|
MTRNR2L11
|
MT-RNR2-like 11 (pseudogene) |
| chr7_+_94536898 | 2.05 |
ENST00000433360.1
ENST00000340694.4 ENST00000424654.1 |
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
| chr4_+_41614909 | 2.05 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr8_-_18666360 | 2.05 |
ENST00000286485.8
|
PSD3
|
pleckstrin and Sec7 domain containing 3 |
| chr11_+_111896320 | 2.03 |
ENST00000531306.1
ENST00000537636.1 |
DLAT
|
dihydrolipoamide S-acetyltransferase |
| chr2_+_97454321 | 2.02 |
ENST00000540067.1
|
CNNM4
|
cyclin M4 |
| chr6_+_62284008 | 2.02 |
ENST00000544932.1
|
MTRNR2L9
|
MT-RNR2-like 9 (pseudogene) |
| chr11_+_86667117 | 2.00 |
ENST00000531827.1
|
RP11-736K20.6
|
RP11-736K20.6 |
| chr4_-_186732048 | 1.99 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr17_+_53345080 | 1.98 |
ENST00000572002.1
|
HLF
|
hepatic leukemia factor |
| chr2_+_46770531 | 1.98 |
ENST00000482449.2
|
RHOQ
|
ras homolog family member Q |
| chr17_-_42988004 | 1.97 |
ENST00000586125.1
ENST00000591880.1 |
GFAP
|
glial fibrillary acidic protein |
| chr14_+_22963806 | 1.95 |
ENST00000390493.1
|
TRAJ44
|
T cell receptor alpha joining 44 |
| chr10_-_61122934 | 1.93 |
ENST00000512919.1
|
FAM13C
|
family with sequence similarity 13, member C |
| chr15_-_44487408 | 1.91 |
ENST00000402883.1
ENST00000417257.1 |
FRMD5
|
FERM domain containing 5 |
| chr3_+_173302222 | 1.91 |
ENST00000361589.4
|
NLGN1
|
neuroligin 1 |
| chr20_+_53092123 | 1.90 |
ENST00000262593.5
|
DOK5
|
docking protein 5 |
| chr4_-_111563279 | 1.89 |
ENST00000511837.1
|
PITX2
|
paired-like homeodomain 2 |
| chr22_-_33968239 | 1.88 |
ENST00000452586.2
ENST00000421768.1 |
LARGE
|
like-glycosyltransferase |
| chr6_+_146348782 | 1.85 |
ENST00000361719.2
ENST00000392299.2 |
GRM1
|
glutamate receptor, metabotropic 1 |
| chr2_-_207023918 | 1.85 |
ENST00000455934.2
ENST00000449699.1 ENST00000454195.1 |
NDUFS1
|
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) |
| chr12_+_58013693 | 1.84 |
ENST00000320442.4
ENST00000379218.2 |
SLC26A10
|
solute carrier family 26, member 10 |
| chr12_-_16760195 | 1.84 |
ENST00000546281.1
ENST00000537757.1 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr16_+_21964662 | 1.83 |
ENST00000561553.1
ENST00000565331.1 |
UQCRC2
|
ubiquinol-cytochrome c reductase core protein II |
| chr14_-_21491477 | 1.83 |
ENST00000298684.5
ENST00000557169.1 ENST00000553563.1 |
NDRG2
|
NDRG family member 2 |
| chr2_+_220491973 | 1.82 |
ENST00000358055.3
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
| chr17_+_48610074 | 1.82 |
ENST00000503690.1
ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3
|
epsin 3 |
| chr11_+_20044375 | 1.80 |
ENST00000525322.1
ENST00000530408.1 |
NAV2
|
neuron navigator 2 |
| chr17_+_53344945 | 1.80 |
ENST00000575345.1
|
HLF
|
hepatic leukemia factor |
| chr3_-_46000064 | 1.79 |
ENST00000433878.1
|
FYCO1
|
FYVE and coiled-coil domain containing 1 |
| chr8_+_96037205 | 1.77 |
ENST00000396124.4
|
NDUFAF6
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 |
| chr11_-_790060 | 1.77 |
ENST00000330106.4
|
CEND1
|
cell cycle exit and neuronal differentiation 1 |
| chr20_+_57875457 | 1.76 |
ENST00000337938.2
ENST00000311585.7 ENST00000371028.2 |
EDN3
|
endothelin 3 |
| chr2_+_103378472 | 1.75 |
ENST00000412401.2
|
TMEM182
|
transmembrane protein 182 |
| chr4_-_186696425 | 1.73 |
ENST00000430503.1
ENST00000319454.6 ENST00000450341.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr2_-_207024233 | 1.73 |
ENST00000423725.1
ENST00000233190.6 |
NDUFS1
|
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) |
| chrM_-_14670 | 1.73 |
ENST00000361681.2
|
MT-ND6
|
mitochondrially encoded NADH dehydrogenase 6 |
| chr19_-_4517613 | 1.72 |
ENST00000301286.3
|
PLIN4
|
perilipin 4 |
| chr4_-_186696515 | 1.69 |
ENST00000456596.1
ENST00000414724.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr3_-_52002194 | 1.69 |
ENST00000466412.1
|
PCBP4
|
poly(rC) binding protein 4 |
| chr17_+_48610042 | 1.69 |
ENST00000503246.1
|
EPN3
|
epsin 3 |
| chr14_-_102976135 | 1.68 |
ENST00000560748.1
|
ANKRD9
|
ankyrin repeat domain 9 |
| chr14_-_23395623 | 1.68 |
ENST00000556043.1
|
PRMT5
|
protein arginine methyltransferase 5 |
| chr1_+_36621174 | 1.68 |
ENST00000429533.2
|
MAP7D1
|
MAP7 domain containing 1 |
| chr14_-_102976091 | 1.67 |
ENST00000286918.4
|
ANKRD9
|
ankyrin repeat domain 9 |
| chr14_-_73360796 | 1.66 |
ENST00000556509.1
ENST00000541685.1 ENST00000546183.1 |
DPF3
|
D4, zinc and double PHD fingers, family 3 |
| chr3_+_37284824 | 1.66 |
ENST00000431105.1
|
GOLGA4
|
golgin A4 |
| chr7_+_35756186 | 1.66 |
ENST00000430518.1
|
AC018647.3
|
AC018647.3 |
| chr22_-_24110063 | 1.66 |
ENST00000520222.1
ENST00000401675.3 |
CHCHD10
|
coiled-coil-helix-coiled-coil-helix domain containing 10 |
| chr4_+_159593418 | 1.65 |
ENST00000507475.1
ENST00000307738.5 |
ETFDH
|
electron-transferring-flavoprotein dehydrogenase |
| chr1_+_36024107 | 1.65 |
ENST00000437806.1
|
NCDN
|
neurochondrin |
| chr17_-_4889508 | 1.65 |
ENST00000574606.2
|
CAMTA2
|
calmodulin binding transcription activator 2 |
| chr3_-_18480173 | 1.64 |
ENST00000414509.1
|
SATB1
|
SATB homeobox 1 |
| chr2_+_219472637 | 1.64 |
ENST00000417849.1
|
PLCD4
|
phospholipase C, delta 4 |
| chr19_-_48867171 | 1.63 |
ENST00000377431.2
ENST00000436660.2 ENST00000541566.1 |
TMEM143
|
transmembrane protein 143 |
| chr11_+_22696314 | 1.63 |
ENST00000532398.1
ENST00000433790.1 |
GAS2
|
growth arrest-specific 2 |
| chr3_+_160559931 | 1.63 |
ENST00000464260.1
ENST00000295839.9 |
PPM1L
|
protein phosphatase, Mg2+/Mn2+ dependent, 1L |
| chr19_-_4722780 | 1.61 |
ENST00000600621.1
|
DPP9
|
dipeptidyl-peptidase 9 |
| chr3_-_71777824 | 1.60 |
ENST00000469524.1
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3 |
| chr17_-_1553346 | 1.60 |
ENST00000301336.6
|
RILP
|
Rab interacting lysosomal protein |
| chr14_-_80677970 | 1.60 |
ENST00000438257.4
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr10_+_116853091 | 1.60 |
ENST00000526946.1
|
ATRNL1
|
attractin-like 1 |
| chr15_+_23810903 | 1.60 |
ENST00000564592.1
|
MKRN3
|
makorin ring finger protein 3 |
| chrM_+_14741 | 1.60 |
ENST00000361789.2
|
MT-CYB
|
mitochondrially encoded cytochrome b |
| chr17_-_9939854 | 1.59 |
ENST00000584146.2
|
GAS7
|
growth arrest-specific 7 |
| chr7_-_123198284 | 1.58 |
ENST00000355749.2
|
NDUFA5
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 |
| chr8_-_53626974 | 1.58 |
ENST00000435644.2
ENST00000518710.1 ENST00000025008.5 ENST00000517963.1 |
RB1CC1
|
RB1-inducible coiled-coil 1 |
| chr2_-_44223089 | 1.56 |
ENST00000447246.1
ENST00000409946.1 ENST00000409659.1 |
LRPPRC
|
leucine-rich pentatricopeptide repeat containing |
| chr14_-_80677815 | 1.55 |
ENST00000557125.1
ENST00000555750.1 |
DIO2
|
deiodinase, iodothyronine, type II |
| chr1_+_46769303 | 1.54 |
ENST00000311672.5
|
UQCRH
|
ubiquinol-cytochrome c reductase hinge protein |
| chr2_+_219472488 | 1.54 |
ENST00000450993.2
|
PLCD4
|
phospholipase C, delta 4 |
| chr5_+_67535647 | 1.53 |
ENST00000520675.1
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
| chr15_+_71145578 | 1.53 |
ENST00000544974.2
ENST00000558546.1 |
LRRC49
|
leucine rich repeat containing 49 |
| chr11_+_73357614 | 1.53 |
ENST00000536527.1
|
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
| chr17_+_48609903 | 1.52 |
ENST00000268933.3
|
EPN3
|
epsin 3 |
| chr12_-_16758873 | 1.52 |
ENST00000535535.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr7_-_123197733 | 1.51 |
ENST00000470123.1
ENST00000471770.1 |
NDUFA5
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 |
| chr14_-_80677613 | 1.51 |
ENST00000556811.1
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr22_+_18121562 | 1.50 |
ENST00000355028.3
|
BCL2L13
|
BCL2-like 13 (apoptosis facilitator) |
| chr17_+_7123207 | 1.50 |
ENST00000584103.1
ENST00000579886.2 |
ACADVL
|
acyl-CoA dehydrogenase, very long chain |
| chr20_+_58179582 | 1.49 |
ENST00000371015.1
ENST00000395639.4 |
PHACTR3
|
phosphatase and actin regulator 3 |
| chr4_+_72204755 | 1.49 |
ENST00000512686.1
ENST00000340595.3 |
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
| chr17_+_22022437 | 1.49 |
ENST00000540040.1
|
MTRNR2L1
|
MT-RNR2-like 1 |
| chr11_-_117170403 | 1.48 |
ENST00000504995.1
|
BACE1
|
beta-site APP-cleaving enzyme 1 |
| chr1_+_16062820 | 1.48 |
ENST00000294454.5
|
SLC25A34
|
solute carrier family 25, member 34 |
| chr17_+_7348374 | 1.48 |
ENST00000306071.2
ENST00000572857.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
| chr22_+_18121356 | 1.47 |
ENST00000317582.5
ENST00000543133.1 ENST00000538149.1 ENST00000337612.5 ENST00000493680.1 |
BCL2L13
|
BCL2-like 13 (apoptosis facilitator) |
| chr19_-_4722705 | 1.47 |
ENST00000598360.1
|
DPP9
|
dipeptidyl-peptidase 9 |
| chr12_-_47219733 | 1.47 |
ENST00000547477.1
ENST00000447411.1 ENST00000266579.4 |
SLC38A4
|
solute carrier family 38, member 4 |
| chr12_-_56106060 | 1.46 |
ENST00000452168.2
|
ITGA7
|
integrin, alpha 7 |
| chr2_-_241725781 | 1.46 |
ENST00000428768.1
|
KIF1A
|
kinesin family member 1A |
| chr12_-_75601778 | 1.45 |
ENST00000550433.1
ENST00000548513.1 |
KCNC2
|
potassium voltage-gated channel, Shaw-related subfamily, member 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of PPARA
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.4 | 33.5 | GO:0060254 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 2.3 | 7.0 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 2.1 | 8.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 1.9 | 13.4 | GO:1903279 | protein transport into plasma membrane raft(GO:0044861) regulation of calcium:sodium antiporter activity(GO:1903279) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 1.5 | 4.5 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 1.2 | 3.5 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 1.1 | 4.4 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.9 | 11.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.9 | 7.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.9 | 2.7 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.9 | 2.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.9 | 5.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.9 | 2.6 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.9 | 4.3 | GO:0060127 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
| 0.8 | 8.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.8 | 6.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.7 | 6.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.7 | 10.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.7 | 13.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.7 | 8.6 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.7 | 2.7 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.6 | 1.9 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.6 | 5.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.6 | 9.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.6 | 3.9 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.5 | 0.5 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
| 0.5 | 1.6 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.5 | 3.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 | 1.5 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.5 | 9.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.5 | 1.9 | GO:0098942 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.5 | 3.3 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.5 | 0.9 | GO:0042310 | regulation of vasoconstriction(GO:0019229) vasoconstriction(GO:0042310) |
| 0.5 | 1.9 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.5 | 1.4 | GO:1902868 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.5 | 3.7 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.5 | 6.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.5 | 1.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.4 | 3.1 | GO:0014826 | cellular magnesium ion homeostasis(GO:0010961) vein smooth muscle contraction(GO:0014826) |
| 0.4 | 2.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.4 | 1.7 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.4 | 2.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.4 | 1.2 | GO:0050894 | determination of affect(GO:0050894) |
| 0.4 | 3.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.4 | 1.2 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.4 | 28.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.4 | 8.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.4 | 6.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.4 | 1.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 | 1.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.3 | 6.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.3 | 1.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.3 | 3.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.3 | 11.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 | 2.7 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.3 | 9.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 | 1.3 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.3 | 0.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.3 | 2.8 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.3 | 0.9 | GO:0044335 | neural crest cell fate commitment(GO:0014034) canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
| 0.3 | 0.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 | 23.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.3 | 2.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 | 1.1 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.3 | 3.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.3 | 6.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 | 5.4 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.3 | 0.8 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.3 | 0.3 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.3 | 4.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.3 | 3.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.3 | 1.0 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
| 0.2 | 2.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 | 1.0 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.2 | 1.7 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.2 | 3.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.2 | 1.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.2 | 0.7 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.2 | 3.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.2 | 2.0 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.2 | 6.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 | 0.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 1.8 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.2 | 0.4 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 0.6 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.2 | 4.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 9.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.2 | 1.4 | GO:0035900 | isocitrate metabolic process(GO:0006102) response to isolation stress(GO:0035900) |
| 0.2 | 4.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.2 | 1.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 | 1.6 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.2 | 1.6 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
| 0.2 | 1.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 | 1.0 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.2 | 0.9 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 | 2.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.2 | 8.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 1.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.2 | 1.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.2 | 1.1 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.2 | 1.6 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 0.9 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.2 | 0.5 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.2 | 0.5 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.2 | 0.5 | GO:1903121 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 | 0.7 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 0.2 | 3.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 | 3.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) angiotensin-mediated drinking behavior(GO:0003051) |
| 0.2 | 2.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 0.8 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.2 | 1.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 0.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.2 | 3.0 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 1.0 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 3.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 2.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.6 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 1.1 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
| 0.1 | 4.2 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 2.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.6 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 0.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.9 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.1 | 2.6 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 1.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 1.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 0.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 2.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 | 2.4 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 2.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.9 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 2.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.1 | 0.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.1 | 0.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 | 3.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.1 | 0.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 2.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 0.7 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 0.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.1 | 1.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 1.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 | 2.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.1 | 2.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 1.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 0.7 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 0.3 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.1 | 0.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 | 4.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 2.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.4 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 1.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 | 0.7 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.1 | 1.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 1.7 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.9 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 2.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 1.2 | GO:0015866 | ADP transport(GO:0015866) |
| 0.1 | 0.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 3.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.1 | 1.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 1.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 | 0.3 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 | 0.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 1.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 1.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 | 1.7 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.1 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 | 1.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 | 1.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.1 | 0.9 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 1.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.1 | 0.1 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 1.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 1.3 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 2.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 0.5 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 3.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.1 | 1.4 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
| 0.1 | 2.0 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 0.7 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 0.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 1.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 1.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 1.8 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 0.3 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.1 | 1.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 0.4 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.1 | 1.5 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.4 | GO:0006814 | sodium ion transport(GO:0006814) |
| 0.1 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 12.0 | GO:0006941 | striated muscle contraction(GO:0006941) |
| 0.0 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.0 | 1.0 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 4.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 3.8 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.0 | 3.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 1.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 | 1.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 1.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 0.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.0 | 0.4 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 | 3.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.0 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.0 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
| 0.0 | 0.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 | 1.2 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.2 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.0 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 1.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.5 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 1.3 | GO:0008361 | regulation of cell size(GO:0008361) |
| 0.0 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.0 | 0.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 2.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.6 | GO:0010962 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) regulation of polysaccharide biosynthetic process(GO:0032885) |
| 0.0 | 3.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 1.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 | 0.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.0 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
| 0.0 | 2.2 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.0 | 2.5 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 | 1.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 | 1.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 | 1.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.0 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 1.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 | 0.7 | GO:0010458 | exit from mitosis(GO:0010458) |
| 0.0 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.0 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.0 | 3.1 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 1.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
| 0.0 | 3.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 | 0.7 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.0 | 1.3 | GO:0009725 | response to hormone(GO:0009725) |
| 0.0 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.0 | 0.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 0.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.0 | 0.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.4 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 | 0.6 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
| 0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 3.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 | 0.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.4 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
| 0.0 | 1.0 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.2 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.0 | 0.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 | 0.3 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.4 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
| 0.0 | 0.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 | 0.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 | 0.9 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.0 | 0.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.0 | 0.8 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.0 | 1.6 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.0 | 2.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 2.8 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 1.1 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.0 | 3.5 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.0 | 0.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.0 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.0 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.4 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 8.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.2 | 10.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 1.0 | 4.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 1.0 | 6.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 1.0 | 7.2 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
| 1.0 | 6.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.9 | 2.8 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.9 | 22.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.7 | 11.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.7 | 8.2 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.6 | 3.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.5 | 6.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.5 | 6.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.5 | 3.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.5 | 1.9 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.4 | 8.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.4 | 1.5 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.4 | 6.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.3 | 1.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.3 | 11.0 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 4.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 1.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.3 | 1.7 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.3 | 1.6 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 17.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.2 | 0.7 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.2 | 1.0 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.2 | 1.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.2 | 1.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.2 | 5.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 2.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.2 | 9.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.2 | 10.8 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 2.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 1.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.2 | 0.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.2 | 1.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.2 | 4.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.2 | 4.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.2 | 0.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.2 | 3.5 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.2 | 1.6 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 1.7 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 1.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 3.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.1 | 1.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 3.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 6.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.1 | 2.1 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 3.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 1.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.1 | 10.9 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 3.6 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 0.9 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 4.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.1 | 7.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 1.8 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.1 | 1.6 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 1.6 | GO:0097025 | lateral loop(GO:0043219) MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 0.9 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 20.5 | GO:0030017 | sarcomere(GO:0030017) |
| 0.1 | 1.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 2.8 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 1.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 25.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 1.9 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 2.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.3 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 1.5 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 4.1 | GO:0008305 | integrin complex(GO:0008305) |
| 0.1 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
| 0.1 | 1.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 2.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 1.7 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 9.6 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 1.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 5.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 2.2 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 12.6 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 1.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 2.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.0 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.0 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.0 | 0.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 2.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.8 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 38.4 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 15.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 3.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.0 | 0.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.0 | 1.2 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 5.6 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 2.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 1.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.0 | 16.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 0.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.0 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 1.5 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 1.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 1.2 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.6 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.0 | 2.2 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 5.8 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.0 | 1.9 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 1.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 5.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 1.2 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
| 0.0 | 0.7 | GO:0012505 | endomembrane system(GO:0012505) |
| 0.0 | 0.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 1.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.0 | 0.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 1.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 1.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 1.7 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 1.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 1.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.7 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 1.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.9 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 0.1 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) Lewy body core(GO:1990037) |
| 0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 8.8 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.8 | 9.1 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 1.5 | 7.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 1.4 | 4.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 1.3 | 5.0 | GO:1990175 | EH domain binding(GO:1990175) |
| 1.1 | 4.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 1.1 | 26.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.9 | 3.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.8 | 2.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.8 | 6.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.7 | 2.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.7 | 9.8 | GO:0052658 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.6 | 4.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.6 | 3.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.6 | 1.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.6 | 4.7 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.6 | 1.7 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.5 | 3.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.5 | 2.0 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.5 | 3.5 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.5 | 3.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.5 | 4.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.5 | 4.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.5 | 1.9 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.5 | 7.2 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.4 | 0.9 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.4 | 2.2 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.4 | 3.0 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.4 | 25.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.4 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.4 | 1.2 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.4 | 1.1 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.4 | 2.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.3 | 2.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.3 | 1.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.3 | 3.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.3 | 6.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.3 | 2.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.3 | 10.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.3 | 3.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.3 | 1.6 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.3 | 2.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.3 | 1.5 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 1.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.3 | 5.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.3 | 1.1 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.3 | 1.4 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.3 | 12.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.3 | 2.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.3 | 1.0 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 1.7 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.2 | 1.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 1.1 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.2 | 0.7 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.2 | 0.9 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.2 | 0.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 1.3 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.2 | 0.8 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 0.2 | 1.0 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.2 | 1.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.2 | 1.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.2 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.2 | 5.3 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 6.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 7.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 0.5 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.2 | 1.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.2 | 4.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 5.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.2 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.2 | 0.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 3.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 0.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 0.4 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.1 | 0.7 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.1 | 0.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.1 | 2.6 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.1 | 11.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.1 | 1.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 0.1 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
| 0.1 | 1.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 1.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.1 | 9.2 | GO:0043531 | ADP binding(GO:0043531) |
| 0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 0.9 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
| 0.1 | 1.6 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 1.1 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 1.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 3.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 4.1 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 1.2 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 1.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 2.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 0.6 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 2.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 4.3 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 1.9 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 0.9 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.1 | 0.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 2.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 2.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 1.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.1 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.1 | 2.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 2.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 0.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.1 | 0.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.1 | 2.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 1.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.2 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 3.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 2.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 4.3 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 2.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.1 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 0.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.1 | 2.6 | GO:0051020 | GTPase binding(GO:0051020) |
| 0.1 | 1.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 1.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 1.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 1.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.1 | 5.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 23.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.1 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 3.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 2.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 0.8 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.1 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.2 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.1 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.0 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.0 | 1.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 1.8 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 2.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 2.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 1.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.0 | 2.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 2.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 3.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 2.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 1.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.0 | 0.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.0 | 1.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 5.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 1.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 1.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 1.9 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 3.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.0 | 0.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.0 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.0 | 1.3 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 2.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 1.9 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 2.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 1.8 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 5.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 3.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.3 | GO:1901611 | phosphatidylinositol transporter activity(GO:0008526) phosphatidylglycerol binding(GO:1901611) |
| 0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 1.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.0 | 3.7 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 1.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.0 | 1.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 2.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.0 | 0.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.0 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.0 | 1.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 1.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 12.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 1.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 1.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.0 | 0.5 | GO:0071949 | FAD binding(GO:0071949) |
| 0.0 | 0.9 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.0 | 0.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.6 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.0 | 0.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 1.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 5.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 5.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 2.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 4.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 11.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 9.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 1.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 5.6 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 3.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.2 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 2.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 3.2 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 1.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 1.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 3.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 1.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.0 | 1.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.0 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 1.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 1.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 1.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.4 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 1.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 9.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.4 | 9.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.4 | 26.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.4 | 12.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.4 | 34.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.3 | 8.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.2 | 3.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.2 | 17.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 3.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 11.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 4.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.2 | 3.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 5.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 3.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 5.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 4.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 2.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 1.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 1.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.1 | 1.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 4.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 2.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 2.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.1 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 3.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 1.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 2.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 2.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.0 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 5.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.0 | 1.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 1.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 2.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 1.7 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 1.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 1.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.0 | 8.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 1.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 1.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 4.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 1.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.0 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 1.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 1.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |